AnterogenCoLtd Revenue vs. EBITDA
| 065660 Stock | KRW 16,950 1,380 8.86% |
For AnterogenCoLtd profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AnterogenCoLtd to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AnterogenCoLtd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AnterogenCoLtd's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AnterogenCoLtd over time as well as its relative position and ranking within its peers.
AnterogenCoLtd |
AnterogenCoLtd EBITDA vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining AnterogenCoLtd's current stock value. Our valuation model uses many indicators to compare AnterogenCoLtd value to that of its competitors to determine the firm's financial worth. AnterogenCoLtd is the top company in revenue category among its peers. It also is number one stock in ebitda category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AnterogenCoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AnterogenCoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AnterogenCoLtd Revenue vs. Competition
AnterogenCoLtd is the top company in revenue category among its peers. Market size based on revenue of Pharmaceuticals industry is presently estimated at about 34.44 Billion. AnterogenCoLtd totals roughly 8.12 Billion in revenue claiming about 24% of equities listed under Pharmaceuticals industry.
AnterogenCoLtd EBITDA vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
AnterogenCoLtd |
| = | 8.12 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
AnterogenCoLtd |
| = | (2.96 B) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
AnterogenCoLtd Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AnterogenCoLtd, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AnterogenCoLtd will eventually generate negative long term returns. The profitability progress is the general direction of AnterogenCoLtd's change in net profit over the period of time. It can combine multiple indicators of AnterogenCoLtd, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea.
AnterogenCoLtd Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on AnterogenCoLtd. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AnterogenCoLtd position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AnterogenCoLtd's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in AnterogenCoLtd without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Use Investing Themes to Complement your AnterogenCoLtd position
In addition to having AnterogenCoLtd in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recycling Thematic Idea Now
Recycling
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in AnterogenCoLtd Stock
To fully project AnterogenCoLtd's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AnterogenCoLtd at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AnterogenCoLtd's income statement, its balance sheet, and the statement of cash flows.